SEC Form 4 · accession 0001127602-17-001306
Alkermes plc. · ALKS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliot Ehrich
Officer — EVP, R&D & CMO, Alkermes, Inc.
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 6:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jan 4, 2017 | M | 7,500 | $18.105 | A | 60,140 | D | |
| Ordinary SharesF3 | Jan 4, 2017 | S | 5,000 | $58.8252 | D | 55,140 | D | |
| Ordinary SharesF4 | Jan 4, 2017 | S | 2,500 | $60.0088 | D | 52,640 | D | |
| Ordinary Shares | Jan 5, 2017 | M | 400 | $18.105 | A | 53,040 | D | |
| Ordinary SharesF5 | Jan 5, 2017 | S | 400 | $60.0775 | D | 52,640 | D | |
| Ordinary Shares | Jan 6, 2017 | M | 2,100 | $18.105 | A | 54,740 | D | |
| Ordinary SharesF6 | Jan 6, 2017 | S | 2,100 | $60.1173 | D | 52,640 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F7 | $18.105 | Jan 4, 2017 | M | 7,500 | D | — | May 20, 2021 | Ordinary Shares | 7,500 | 8,500 | D |
| Employee Stock Option (Right to Buy)F7 | $18.105 | Jan 5, 2017 | M | 400 | D | — | May 20, 2021 | Ordinary Shares | 400 | 8,100 | D |
| Employee Stock Option (Right to Buy)F7 | $18.105 | Jan 6, 2017 | M | 2,100 | D | — | May 20, 2021 | Ordinary Shares | 2,100 | 6,000 | D |
Explanation of responses
- F1This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.80 to $59.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F5The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Cancel
- F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- F7These options are fully vested in accordance with their terms.